<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-8043</identifier>
<setSpec>0001-6519</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Lymphocytes of patients with auto-immune deafness present type II collagen hyporeactivity in the presence of the pineal hormone melatonin</dc:title>
<dc:description xml:lang="en">A study was made of the behavior of peripheral blood lymphocytes in healthy controls and patients with various types of hearing loss. Hearing loss of auto-immune origin was studied in the presence and absence of melatonin, activated or not by concanavalin A. In patients with auto-immune hearing loss, lymphocytes showed hyporeactivity to type II collagen in terms of proliferative activity in the presence of concavalin A. Hyporeactivity was especially relevant in melatonin-incubated cells. In different nosologic entities, lymphocyte hyporeactivity to type II collagen was similar in bilateral sensorineural hearing loss, Ménière's disease and otosclerosis. We conclude that the lymphocytes of patients with autoimmune hearing loss showed hyporeactivity to type II collagen when compared to lymphocytes from control subjects. This hyporeactivity was revealed when lymphocytes were activated in the presence of melatonin (AU)</dc:description>
<dc:publisher>Sanidad y Ediciones (SANED, S.L.)</dc:publisher>
<dc:description xml:lang="es">Linfocitos de sangre periférica obtenidos de controles sanos y de pacientes con diversas sorderas mediadas-por mecanismos autoinmunitarios han sido estudiados en presencia de colágeno tipo II y melatonina, activando previamente los linfocitos mediante concanavalina A. Los resultados muestran una hiporreactividad de los linfocitos frente a colágeno tipo II del total de pacientes con sorderas autoinmunes, únicamente cuando los linfocitos se encuentran en presencia de melatonina, con diferencias estadísticamente significativas. Por entidades nosológicas, hay la misma hiporreactividad en la sordera neurosensorial bilateral, enfermedad de Ménière y otoesclerosis. Concluimos que en linfocitos de pacientes con sorderas autoinmunes existe una hiporreactividad frente a colágeno tipo II cuando se compara con linfocitos de controles sanos y que esta hiporreactividad únicamente se pone de manifiesto en presencia de melatonina cuando los linfocitos están activados (AU)</dc:description>
<dc:source>Acta Otorrinolaringol Esp;51(4): 314-318, mayo 2000. tab</dc:source>
<dc:title xml:lang="es">Linfocitos de pacientes con sorderas autoinmunitarias presentan hiporreactividad a colágeno tipo II en presencia de la hormona pineal melatonina</dc:title>
<dc:type>article</dc:type>
<dc:creator>López González, MA</dc:creator>
<dc:creator>Mata Maderuelo, F</dc:creator>
<dc:creator>Delgado Moreno, F</dc:creator>
<dc:language>es</dc:language>
<dc:identifier>ibc-8043</dc:identifier>
<dc:subject>^d29315</dc:subject>
<dc:subject>^d3655^s22044</dc:subject>
<dc:subject>^d29340^s22044</dc:subject>
<dc:subject>^d8718^s22044</dc:subject>
<dc:subject>^d8745^s22044</dc:subject>
<dc:subject>^d11303</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d3232^s22044</dc:subject>
<dc:subject>^d1333^s22044</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d2500^s22031</dc:subject>
<dc:subject>^d23303^s22044</dc:subject>
<dc:date>200005</dc:date>
</metadata>
</record>
</ibecs-document>
